Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression

[1]  B. Strahl,et al.  Interpreting the language of histone and DNA modifications. , 2014, Biochimica et biophysica acta.

[2]  Qiuping Hu,et al.  JUNB promotes the survival of Flavopiridol treated human breast cancer cells. , 2014, Biochemical and biophysical research communications.

[3]  P. Watson,et al.  Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer , 2014, Oncogene.

[4]  A. Lavecchia,et al.  Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature , 2014, Expert opinion on therapeutic patents.

[5]  J. Lis,et al.  Control of transcriptional elongation. , 2013, Annual review of genetics.

[6]  K. Dahlman-Wright,et al.  Expression of activator protein-1 (AP-1) family members in breast cancer , 2013, BMC Cancer.

[7]  Jianhua Wang,et al.  Stromal cells in tumor microenvironment and breast cancer , 2013, Cancer and Metastasis Reviews.

[8]  F. Mattei,et al.  The Tumor Microenvironment: A Pitch for Multiple Players , 2013, Front. Oncol..

[9]  R. Young,et al.  Transcriptional Regulation and Its Misregulation in Disease , 2013, Cell.

[10]  J. Manley,et al.  The RNA polymerase II CTD coordinates transcription and RNA processing. , 2012, Genes & development.

[11]  L. Murphy,et al.  Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer. , 2012, Endocrine-related cancer.

[12]  F. Gemignani,et al.  A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma. , 2012, Mutation research.

[13]  T. Ørntoft,et al.  Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation , 2012, Oncogene.

[14]  Kyung-Hee Lee,et al.  Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells , 2012, Clinical & Experimental Metastasis.

[15]  Ananda L Roy,et al.  Regulation of primary response genes. , 2011, Molecular cell.

[16]  Xin-Yun Huang,et al.  Signal Transducers and Activators of Transcription 3 (STAT3) Directly Regulates Cytokine-induced Fascin Expression and Is Required for Breast Cancer Cell Migration* , 2011, The Journal of Biological Chemistry.

[17]  Kornelia Polyak,et al.  The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.

[18]  E. Shaulian.  AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? , 2010, Cellular signalling.

[19]  J. Davie,et al.  Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex , 2010, Nucleic acids research.

[20]  N. Hynes,et al.  Key signalling nodes in mammary gland development and cancer: Myc , 2009, Breast Cancer Research.

[21]  F. Martin,et al.  Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development , 2009, Breast Cancer Research.

[22]  P. Schedin,et al.  Macrophages in Breast Cancer: Do Involution Macrophages Account for the Poor Prognosis of Pregnancy-Associated Breast Cancer? , 2009, Journal of mammary gland biology and neoplasia.

[23]  E. Passegué,et al.  JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. , 2009, Cancer cell.

[24]  W. Schlegel,et al.  Negative elongation factor NELF controls transcription of immediate early genes in a stimulus-specific manner. , 2009, Experimental cell research.

[25]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[26]  R. Farràs,et al.  JunB Breakdown in Mid-/Late G2 Is Required for Down-Regulation of Cyclin A2 Levels and Proper Mitosis , 2008, Molecular and Cellular Biology.

[27]  S. Ryser,et al.  Up-Regulation of P-TEFb by the MEK1-Extracellular Signal-Regulated Kinase Signaling Pathway Contributes to Stimulated Transcription Elongation of Immediate Early Genes in Neuroendocrine Cells , 2007, Molecular and Cellular Biology.

[28]  Yingjie Zhang,et al.  The mouse C/EBPδ gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c‐Myc repression , 2007, Journal of cellular biochemistry.

[29]  N. Neamati,et al.  Small molecule inhibitors of Stat3 signaling pathway. , 2007, Current cancer drug targets.

[30]  J. Heath,et al.  Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel. , 2006, Cancer research.

[31]  E. Shaulian,et al.  Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence* , 2006, Journal of Biological Chemistry.

[32]  H. Handa,et al.  Transcriptional Pausing Caused by NELF Plays a Dual Role in Regulating Immediate-Early Expression of the junB Gene , 2006, Molecular and Cellular Biology.

[33]  Ali Shilatifard,et al.  Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. , 2006, Annual review of biochemistry.

[34]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[35]  J. Blenis,et al.  MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.

[36]  Yanhui Hu,et al.  Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. , 2006, Journal of proteome research.

[37]  S. Ramaswamy,et al.  Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. , 2005, Cancer research.

[38]  J. Davie,et al.  The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[39]  Rosette Lidereau,et al.  Molecular Profiling of Inflammatory Breast Cancer , 2004, Clinical Cancer Research.

[40]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[41]  Jan-Gowth Chang,et al.  JunB gene expression is inactivated by methylation in chronic myeloid leukemia. , 2003, Blood.

[42]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[43]  J. Dewille,et al.  Oncostatin M Induces Growth Arrest of Mammary Epithelium via a CCAAT/enhancer-binding Protein δ-dependent Pathway1Supported in part by NIH Grant RR00136CA (to J. A. H.) and NIH Grants CA 57607 and P30CA16058 from the National Cancer Institute (to J. W. D.).1 , 2002 .

[44]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[45]  J. O’Rourke,et al.  Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein δ Gene Transcription in G0Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland* , 2000, The Journal of Biological Chemistry.

[46]  小島 裕正.  IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s) , 1996 .

[47]  A. Loubat,et al.  Two Distinct Signalling Pathways Are Involved in the Control of the Biphasic junB Transcription Induced by Interleukin-6 in the B Cell Hybridoma 7TD1 (*) , 1995, The Journal of Biological Chemistry.

[48]  J. Davie,et al.  Immediate early response genes and cell transformation. , 2013, Pharmacology & therapeutics.

[49]  J. Davie,et al.  Nucleosomal response, immediate-early gene expression and cell transformation. , 2010, Advances in enzyme regulation.

[50]  Stephen L. Abrams,et al.  Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. , 2006, Advances in enzyme regulation.

[51]  J. Dewille,et al.  CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines. , 2004, Journal of Cellular Biochemistry.

[52]  Fred R. Miller,et al.  Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.

[53]  A. Miyajima,et al.  Oncostatin M, a multifunctional cytokine. , 2003, Reviews of physiology, biochemistry and pharmacology.

[54]  J. Dewille,et al.  Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway. , 2002, Molecular cancer therapeutics.

[55]  K. L. Woodward,et al.  A question of life or death. , 2001, Newsweek.

[56]  J. O’Rourke,et al.  Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland. , 2000, The Journal of biological chemistry.